RAPP EDWARD J 4

What Happened
Edward J. Rapp, a director of AbbVie Inc. (ABBV), was granted 1,118 restricted stock units (RSUs) on 2026-05-08. The award was recorded at $0.00 per share (no cash paid). These RSUs will be settled on a one-for-one basis into AbbVie common stock upon the earlier of the director’s separation from service, death, or a change in control under the company’s 2013 Incentive Stock Program.

Key Details

• Transaction date: 2026-05-08 (Form filed 2026-05-12). Filing appears timely (within two business days).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 1,118 RSUs; reported price $0.00.
• Shares owned/holdings: Form notes total holdings include 10,388 shares in trust that were previously held indirectly by the spouse and are now held directly. The 1,118 RSUs will convert to shares only upon the trigger events noted above.
• Footnotes: F1 — RSUs awarded under AbbVie’s Amended and Restated 2013 Incentive Stock Program; F2 — previously indirect holdings (10,388 shares) now held directly.
• Economic impact: No immediate cash or share transfer occurred; this is a compensation award, not an open-market purchase or sale.

Context
Director RSU awards are routine compensation and do not represent an immediate purchase or sale of shares. Because the RSUs convert to common stock only upon separation, death, or a change in control, they do not reflect an immediate change in voting power or liquidity.